It will depend on our capacity to regulate the two immune system components—innate immunity, as was discussed above, and adaptive immunity—whether we can manipulate immune function by augmenting it or reducing it.
The innate immune system serves as the body's initial line of defence.
The body's innate immune system is the first to notice foreign invaders such viruses, germs, parasites, and poisons, as well as injuries or trauma. The innate immune response, which is the body's initial line of defence, stimulates cells to fight and eliminate these agents or events or to start the healing process. It also informs and modifies the adaptive immune response, which comes next.
Adaptive immunity: the second, focused reaction
The second and most focused line of defence is made up of adaptive immune cells, The innate immune system triggers their response. After identifying the intruder, the cells can grow and fight it, resulting in disease healing and defence against its recurrence.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia